|
|||||
A new clinical trial is testing a diabetes management program that includes Internet-connected glucose meters and one-on-one coaching against smartphone-enabled glucose meters alone. . . . → Read More: Trial Tests Diabetes Mgmt. Program vs. Smartphone Glucose Meter 
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses. . . . → Read More: DNA-Encoded Synthetic Antibodies Protect Against Ebola 
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. . . . → Read More: Biotechs to Develop Personal Cancer-Killing Virus Vaccines 
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round 
Two institutions in Massachusetts are starting a program to help inventors and new enterprises anywhere in the U.S. bring their point-of-care medical devices to market. . . . → Read More: NIH Funds Support for Point-of-Care Device Entrepreneurs 
A smartphone app that monitors heart functions like an electrocardiogram, or EKG, can detect a dangerous form of heart attack, according to results of a clinical trial. . . . → Read More: Phone App Shown to Detect Serious Heart Attack 
Our friends at Statista posted a chart showing the median number of deaths by country in Europe from microbes resistant to antibiotics, this weekend’s infographic. . . . → Read More: Infographic – Superbugs Annually Kill 33,000 in Europe 
The Food and Drug Administration says it’s streamlining policies for making drugs and medical devices in clinical trials or under review available for people in the U.S. with life-threatening conditions. . . . → Read More: FDA Updating Expanded Access to Investigational Drugs, Devices 
Harvard Medical School is the recipient of a gift from the Blavatnik Family Foundation to develop innovative treatments, apply advanced digital technologies, and accelerate biotech and life science start-up companies. . . . → Read More: $200M Gift Supporting Translational Research, Start-Up Incubator 
A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own. . . . → Read More: Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
